Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Interferon-Beta Gene Transfer (Ad.hIFN-β) in the Treatment of Refractory Colorectal Carcinoma With Liver Metastases

NCT00107861 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00107861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Interferon-Beta Gene Transfer (Ad.hIFN-β) in the Treatment of Refractory Colorectal Carcinoma With Liver Metastases
Lead sponsor
Biogen
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2005
Completion date
September 30, 2006
Enrollment
44
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal carcinoma, metastases